Stepan Company (SCL) delivered a clean headline beat in the third quarter. Adjusted EPS came in at $0.94, ahead of the $0.73 consensus and the $0.85 Earnings Whisper number, a 10.6% surprise. Adjusted earnings grew 95.8% year over year. Revenue of $692.15 million rose 17.3% and topped the $634.3 million consensus by 9.1%. GAAP EPS was $0.78 versus $0.47 a year ago, after $5.6 million of pre-tax restructuring charges and a $3.1 million environmental reserve adjustment at the Maywood, NJ site. The central takeaway is that the operating recovery that began in Q2 is real and broadening, and the cost program behind it is outperforming its own targets. Still, the near-doubling of EPS overstates how fast the core business is actually growing.
The quality of the beat deserves scrutiny on two fronts. First, the revenue line is mostly price. Selling price and mix contributed 13 points of the 17% sales gain, largely from passing through higher raw material costs, while reported volume added only 3 points. Organic volume, up 7%, is the better measure of demand. Second, taxes did much of the work. The provision fell to $2.0 million on $19.8 million of pre-tax income, against $5.7 million on $16.5 million a year earlier. GAAP pre-tax income rose about 20%. Adjusted EBITDA rose 18%, to $66.3 million. Those figures are healthy, but they are far from the roughly 96% gain in adjusted EPS. The operating improvement is genuine; the magnitude of the EPS growth leaned on a favorable tax line.
Beneath the headline, the segment story is solid. Surfactant adjusted EBITDA jumped 27% to $48.2 million on 8% organic volume growth. Gains were broad-based across Consumer Products, Construction & Industrial, Oilfield, and Tier 2/3 customers, partly offset by weaker crop demand. Polymers grew only 4%. Double-digit North American volume, led by Spray Foam, absorbed the costs of a regulatory-mandated Germany turnaround that recurs every five years. Specialty Products volume surged 20% as MCT moved into mid-tier price segments, though at a less favorable mix. On the call, management said organic volume accelerated from flat in Q1 to 6% in Q2 and 7% in Q3. It also noted that pricing now largely offsets raw material inflation and described share gains in Latin America and Mexico against Asian imports as largely sustainable. Sequentially, adjusted EBITDA eased from $74.4 million in Q2. Management had flagged a $5 to $10 million pre-buy pull-forward in Q2 and suggested investors average the two quarters, roughly $140 million combined.
The most consequential update was Project Catalyst. Management raised expected 2026 savings to $66 to $70 million from the prior ~$60 million target. The quarterly run rate is now about $23 million, up from $18 to $20 million last quarter, and management expects it to average more than $25 million per quarter in 2027. That is a structural earnings tailwind independent of the demand cycle. Balance-sheet progress is also visible:
- Net leverage fell to 2.4x from 2.7x in Q1.
- Free cash flow turned positive at $8.2 million after two negative quarters, though a $32 million working capital build limited it.
- The $28.5 million Millsdale land sale closed in October, with proceeds going to debt paydown.
- The dividend rose 2.5%, marking a 59th consecutive annual increase.
Bears have legitimate ammunition for the next quarter. Management explicitly guided to lower Q4 volume growth. A U.S. PA turnaround will land in Q4 as part of a $4 to $5 million second-half maintenance headwind. Crop demand is soft amid ag-industry stress, European and Chinese polymer demand remains weak, and Middle East tensions are driving raw material volatility with some pricing adjustments still pending. Full-year guidance stayed qualitative: adjusted EBITDA growth, positive free cash flow, and continued deleveraging, with no numeric range.
The market setup is constructive but not euphoric. Investor sentiment improved from 0.08 to 0.17 heading into the report, a meaningful shift that still sits only modestly in positive territory. Shares closed at $65.21 before the release, up 4.0% since the open following the July report and 15.2% above the 200-day moving average. They had rebounded 10.2% from an October 9 low of $59.19 to within 2.3% of the $66.75 inter-earnings high set the day after the last report. The stock entered earnings near the top of its range, so a Catalyst raise was partly anticipated. The Earnings Whispers momentum and AVWAP trend readings are positive, while the price and sequential-growth trends are neutral.
The bottom line is that Stepan's quarter was better than the consensus implied in the ways that matter most: broad organic volume growth, margin recovery in Surfactants, and cost savings running well ahead of plan. However, the near-doubling of EPS was inflated by a low tax rate. Q4 also carries explicit headwinds from slower volume growth, another plant turnaround, and lingering weakness in crop and international polymers. The credible growth story now rests on Catalyst savings and deleveraging rather than on the headline EPS figure.